Status:
COMPLETED
A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth
Lead Sponsor:
University of Birmingham
Collaborating Sponsors:
University College, London
University of Melbourne
Conditions:
Post-Partum Haemorrhage
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Every six minutes a mother dies from postpartum haemorrhage (PPH) in low-resource countries, in the prime of her life and often leaving behind a young family. In many settings, when a mother dies in c...
Detailed Description
The aim of this trial is evaluate the implementation of early detection and the use of the WHO MOTIVE 'first response' treatment bundle for PPH on clinical, implementation and resource use outcomes. T...
Eligibility Criteria
Inclusion
- Cluster: Health facility is the randomisation unit. Health facilities are eligible for inclusion if they have 1000 to 5000 births a year and provide comprehensive obstetric care with ability to perform surgery for PPH. Health facilities are selected based on being administratively and geographically distinct from each other. Pre-existing implementation of early detection or bundled approach are exclusion criteria
- Research participants: All healthcare providers attending vaginal births at the study facilities.
- Patients: All verified vaginal births in the study facilities
Exclusion
Key Trial Info
Start Date :
October 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 24 2023
Estimated Enrollment :
99659 Patients enrolled
Trial Details
Trial ID
NCT04341662
Start Date
October 13 2020
End Date
March 24 2023
Last Update
April 18 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Nairobi
Nairobi, Kenya
2
Bayero University
Kano, Nigeria
3
Aga Khan University
Karachi, Pakistan
4
University of Cape Town
Cape Town, South Africa